Safety and Immunogenicity of Pertussis Vaccine Immunization during Pregnancy: A Meta-Analysis of Randomized Clinical Trials
- PMID: 36588977
- PMCID: PMC9797314
- DOI: 10.1155/2022/4857872
Safety and Immunogenicity of Pertussis Vaccine Immunization during Pregnancy: A Meta-Analysis of Randomized Clinical Trials
Abstract
The objective of this meta-analysis is to assess the safety and immunogenicity of maternal pertussis vaccination based on randomized clinical trials. PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Internet, and Wan Fang Database were searched from inception up to the 8th of October 2021, using a protocol registered on PROSPERO with no. 42021287717, and a meta-analysis was conducted. We measured pooled geometric mean concentrations (GMCs) for IgG antibodies against pertussis and the incidence of serious adverse events (SAEs). We identified a total of 522 publications, and after a strict screening, we found that 6 RCTs were eligible for our meta-analysis. GMCs were determined with a standardized mean difference (SMD), and the pooled SMD of anti-PT, anti-FHA, and anti-PRN IgG from cord blood were 0.91 (95% CI: 0.58, 1.24), 1.03 (95% CI: (0.70, 1.35)), and 1.55(95% CI: 1.22, 1.88), respectively. The pooled OR of SAEs of women and infants did not show a statistical difference; the pooled ORs were 1.26 (95% CI: 0.78, 2.05); P = 0.35) and 0.61 (95% CI: 0.37, 1.01); p = 0.053), respectively. Infants of immunized women have significantly higher transplacental antibodies for protection against pertussis disease during the first 2 months of life.
Copyright © 2022 Aidibai Simayi et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.Vaccine. 2021 Oct 22;39(44):6545-6552. doi: 10.1016/j.vaccine.2021.09.022. Epub 2021 Sep 29. Vaccine. 2021. PMID: 34598822
-
Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.Eur J Obstet Gynecol Reprod Biol. 2021 Oct;265:212-216. doi: 10.1016/j.ejogrb.2021.08.033. Epub 2021 Sep 2. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34534737
-
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.Hum Vaccin Immunother. 2017 Jan 2;13(1):136-143. doi: 10.1080/21645515.2016.1234555. Epub 2016 Sep 29. Hum Vaccin Immunother. 2017. PMID: 27686283 Free PMC article. Clinical Trial.
-
The optimal strategy for pertussis vaccination: a systematic review and meta-analysis of randomized control trials and real-world data.Am J Obstet Gynecol. 2022 Jan;226(1):52-67.e10. doi: 10.1016/j.ajog.2021.06.096. Epub 2021 Jul 2. Am J Obstet Gynecol. 2022. PMID: 34224687
-
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis.Front Immunol. 2022 Sep 13;13:965971. doi: 10.3389/fimmu.2022.965971. eCollection 2022. Front Immunol. 2022. PMID: 36177017 Free PMC article.
Cited by
-
Research Priorities for Maternal Immunization.Pediatr Infect Dis J. 2025 Feb 1;44(2S):S13-S15. doi: 10.1097/INF.0000000000004587. Epub 2025 Feb 14. Pediatr Infect Dis J. 2025. PMID: 39951066
-
Efficacy, Immunogenicity, and Safety of Pertussis Vaccine During Pregnancy: A Meta-Analysis.Vaccines (Basel). 2025 Jun 20;13(7):666. doi: 10.3390/vaccines13070666. Vaccines (Basel). 2025. PMID: 40733643 Free PMC article. Review.
-
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10. Infect Dis Ther. 2023. PMID: 37815753 Free PMC article. Review.
-
Maternal Immunization: Current Evidence, Progress, and Challenges.Vaccines (Basel). 2025 Apr 24;13(5):450. doi: 10.3390/vaccines13050450. Vaccines (Basel). 2025. PMID: 40432062 Free PMC article. Review.
-
Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study.EClinicalMedicine. 2024 Mar 28;71:102556. doi: 10.1016/j.eclinm.2024.102556. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38586589 Free PMC article.
References
-
- Pertussis vaccines: WHO position paper - september 2015. Weekly Epidemiological Record . 2015;90:433–458. - PubMed
-
- Baclic O., Tunis M., Rotondo J. An Advisory Committee Review Advisory Committee on Immunization (NACI) Ottawa, Canada: Public Health Agency of Canada; 2018. Literature Review on Immunization in Pregnancy with Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Acellular Pertussis (Tdap) Vaccine: Safety, Immunogenicity and Effectiveness. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources